Aethlon Medical (AEMD) news
Recent news
Aethlon Medical shares surge 467% to $8.16 after co enters merger agreement with North Immunology
Aethlon Medical (Nasdaq: AEMD) shares surged 346% premarket on Thursday, reaching $8.16, following the announcement of all-stock merger with North Immunology . The transaction, approved by both companies’ boards, is expected to close Q1 2027 . Under the terms of the merger agreement, pre-merger…
AInvest Wire · Sep 17, 2026Aethlon Medical & North Immunology announcement merger
Aethlon Medical, Inc. (Nasdaq: AEMD) has announced a merger with North Immunology, a strategic move aimed at expanding its therapeutic portfolio and enhancing its focus on oncology and infectious disease treatments. The merger is expected to consolidate resources and accelerate the development of…
AInvest Wire · Sep 17, 2026Aethlon Medical Inc - Pre-merger North Immunology stockholders expected to own approximately 95.25% of combined company
Aethlon Medical Inc. has disclosed that pre-merger North Immunology stockholders are expected to own approximately 95.25% of the combined company following the proposed merger. This structure indicates that North Immunology shareholders will retain a significant majority stake in the newly formed…
AInvest Wire · Sep 17, 2026Aethlon Medical - Stockholders to receive contingent value right for each share held
AInvest Wire · Sep 17, 2026Aethlon Medical - Combined company expected to have pro forma equity value of $346.50 mln
AInvest Wire · Sep 17, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.